NCT07402200 Study of Indoor Air Pollutants and Their Impact in Children's Health and Wellbeing
| NCT ID | NCT07402200 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Montpellier |
| Condition | Allergy |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-02-04 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-02-04 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to identify and assess in real time the impact of the combined action of various types of air and dust pollutants within a classroom on children's health and quality of life, particularly regarding atopic/allergic diseases in children, and on potential exposure to pollutants at home. Participants will answer questionnaires regarding their health and medications, undergo allergy tests, perform non-invasive lung function tests and check blood oxygen levels.
Eligibility Criteria
Inclusion Criteria: * Child included in the SynAir-G observational study * Child and caregiver(s) willing to follow the study procedures * Written informed consent from the child's parents/guardians * For case group, at least one positive answer (yes) to any of the following questions and for control group, negative answers to all the following questions based on the baseline questionnaire administered in the SynAir-G observational study, as shown below.: a. General health i. Does your child have any health problems (if yes to asthma, allergic rhinitis /rhino-conjunctivitis, atopic dermatitis)? b. Asthma i. Has your child ever had wheezing or whistling in the chest in the past 12 months? ii. In the past 12 months, has your child's chest sounded wheezy during or after exercise? iii. In the past 12 months, has your child had a dry cough at night, apart from a cough associated with a cold or chest infection? c. Rhinitis i. In the past 12 months has your child had a problem with sneezing, or a runny, or blocked nose when she/he DID NOT have a cold or the flu? d. Eczema (both answers yes) i. Has your child had this itchy rash at any time in the past 12 months? If so, has this itchy rash at any time affected any of the following places: the folds of the elbows, behind the knees, in front of the ankles, under the buttocks, or around the neck, ears or eyes? e. Food allergy i. Has your child had diagnosed food allergy during last 12 months? * For case group: Diagnosis of asthma/allergic rhinitis/eczema/food allergy (based on SYNAIR-G baseline questionnaire), active during the past year. * For control group: absence of diagnosis of asthma/allergic rhinitis/eczema/food allergy (based on SYNAIR-G baseline questionnaire) Exclusion Criteria: * Child or child's parents/guardians who: 1. Refuse to participate in the project / to give informed consent. 2. Do not want to follow the protocol procedures. 3. Do not read or/and write in French. 4. Plan a long stay outside the region that does not allow them to follow the visit plan. 5. The child is not affiliated to the French social security service
Frequently Asked Questions
Who can join the NCT07402200 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 12 Years, studying Allergy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07402200 currently recruiting?
Yes, NCT07402200 is actively recruiting participants. Visit ClinicalTrials.gov or contact University Hospital, Montpellier to inquire about joining.
Where is the NCT07402200 trial being conducted?
This trial is being conducted at Montpellier, France.
Who is sponsoring the NCT07402200 clinical trial?
NCT07402200 is sponsored by University Hospital, Montpellier. The trial plans to enroll 100 participants.